MARK2 had previously been linked to AD; for example, MARK2-mediated phosphorylation weakens the interaction of tau with microtubules and promotes tau’s cytosolic accumulation39,61 and certain MARK2 sites, such as Ser262, Ser324, and Ser396, are elevated in AD62. Here, MARK2 is linked to Alzheimer disease.